The DOI matches its Crossref record; 102 of the 106 references it cites were found in a registry or an index.
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Open accessAbstract
In 2019-2020 a new coronavirus named SARS-CoV-2 was identified as the causative agent of a several acute respiratory infection named COVID-19, which is causing a worldwide pandemic. There are still many unresolved questions regarding the pathogenesis of this disease and especially the reasons underlying the extremely different clinical course, ranging from asymptomatic forms to severe manifestations, including the Acute Respiratory Distress Syndrome (ARDS). SARS-CoV-2 showed phylogenetic similarities to both SARS-CoV and MERS-CoV viruses, and some of the clinical features are shared between COVID-19 and previously identified beta-coronavirus infections. Available evidence indicate that the so called "cytokine storm" an uncontrolled over-production of soluble markers of inflammation which, in turn, sustain an aberrant systemic inflammatory response, is a major responsible for the occurrence of ARDS. Chemokines are low molecular weight proteins with powerful chemoattractant activity which play a role in the immune cell recruitment during inflammation. This review will be aimed at providing an overview of the current knowledge on the involvement of the chemokine/chemokine-receptor system in the cytokine storm related to SARS-CoV-2 infection. Basic and clinical evidences obtained from previous SARS and MERS epidemics and available data from COVID-19 will be taken into account.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T helper (Th)-1 cytokines, including Interleukin (IL)-1β, IL-6, Interferon (IFN)-γ, Tumor Necrosis Factor (TNF)-α, CXCL10, and CCL2; and Th-2 cytokines, including IL-4, IL-10, and IL-1 receptor antagonist are all elevated in the serum of COVID-19 patients (Coperchini et al., 2020) in a “cytokine storm” typically associated with the illness.”
From Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up (2021) · cites this paper as Coperchini et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
The reproductive number of COVID-19 is higher compared to SARS coronavirus
Liu, Y., Gayle, A. A., Wilder‐Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,243
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Reddy, G. B., Greif, D. N., Rodríguez, J. R., Best, T. M., Greditzer, H. G., & Jose, J. (2020) · HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery · doi:10.1007/s11420-020-09775-3 · Cited by 3
Periodontal connections to the coronavirus disease 2019: An unexplored novel path?
Apu, E. H., Shaikh, M. S., Lone, M. A., & Kabir, R. (2020) · Advances in Human Biology · doi:10.4103/aihb.aihb_72_20 · Cited by 3
Chronic Periodontal Disease and COVID – 19 Complications
Jagannathan, R., Balaji, T. M., Rajendran, S., Prabhu, D. V. R., Varadarajan, S., & Ajitkumar, S. (2021) · Dental Hypotheses · doi:10.4103/denthyp.denthyp_114_20 · Cited by 3
Nonepileptic Myoclonus in COVID-19: Case Report
Hewan, H., Yang, A., Vaddiparti, A., & Keung, B. (2021) · The Neurohospitalist · doi:10.1177/19418744211004315 · Cited by 3
Immune Responses in Patients with COVID-19: An Overview
Kamat, D., Kamat, A., & Mathur, A. (2021) · Pediatric Annals · doi:10.3928/19382359-20210421-02 · Cited by 3
Sutadji, J. C., Widodo, A. D. W., & Indiastuti, D. N. (2021) · Folia Medica Indonesiana · doi:10.20473/fmi.v57i2.21929 · Cited by 3
Mohiuddin, M., & Kasahara, K. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106517 · Cited by 3
A Glimpse into the Diverse Cellular Immunity against SARS-CoV-2
Chang, C., Liu, Y., Jiao, C., Liu, H., Gong, J., Chen, X., & Chang, L. (2021) · Vaccines · doi:10.3390/vaccines9080827 · Cited by 3
The Role of Platelet in Severe and Fatal Forms of COVID-19
Esparza-Ibarra, E. L., Ayala-Luján, J. L., Mendoza-Almanza, B., Gonzalez-Curiel, I. E., Godina-González, S., Hernández-Barrales, M., & Mendoza‐Almanza, G. (2021) · Current Molecular Medicine · doi:10.2174/1566524021666210910112404 · Cited by 3
Yagnik, D. R. (2021) · Journal of Immunological Sciences · doi:10.29245/2578-3009/2021/3.1220 · Cited by 3
Model of Spiritual Culture of Madurese People in Resilience and Adaptation of New Normal
Amir, F., Sulaihah, S., & Wahyudi, R. (2022) · Jurnal Keperawatan Padjadjaran · doi:10.24198/jkp.v10i1.1920 · Cited by 3
Docosahexaenoic Acid Ester of Phloridzin Reduces Inflammation and Insulin Resistance via AMPK
Chen, J., Wu, Z., Wang, J., Si, X., Zhang, R., Sun, T., Dong, Q., Wu, W., & Qiu, Y. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220518102440 · Cited by 5
Mehra, R. K., Gupta, P., & Singh, N. (2022) · Journal of Research in Clinical Medicine · doi:10.34172/jrcm.2022.010 · Cited by 3
Brooks, D., & Levy, C. J. (2021) · INTERNATIONAL JOURNAL OF DIABETES & METABOLIC SYNDROME · doi:10.52106/2771-1331.1003 · Cited by 3
Wang, C., & Young, Y. (2023) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2023.103970 · Cited by 3
Thyroid hormones modifications among COVID-19 patients undergoing pulmonary rehabilitation
Croce, L., Zampogna, E., Coperchini, F., Costa, P., Pignatti, P., Visca, D., Spanevello, A., & Rotondi, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1192561 · Cited by 3
Self-citationSpinal cord infarction attributed to SARS-CoV-2, with post-acute sequelae of COVID-19: A case report
Oleson, C. V., Olsen, A. C., & Shermon, S. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i36.8542 · Cited by 3
COVID-19 in a Down Syndrome Newborn
Pontes, G. C. L., Lobato, A. C. R., da Silva, S. M., da Silva, D. F. A., da Silva, A. F., Rocha, R. S. B., de Oliveira, B. D., Martins, T. O. C., Chermont, A. G., & Cunha, K. D. C. (2020) · International Journal of Clinical Pediatrics · doi:10.14740/ijcp396 · Cited by 3
COVID-19 and the Cytokine Storm
Flowers, L. O. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.29.004833 · Cited by 3
COVID-19 und Nierentransplantation
Regele, F., & Oberbauer, R. W. (2021) · Der Nephrologe · doi:10.1007/s11560-021-00485-3 · Cited by 3
Ramadhan, F., Putra, N. P. P., Setyawan, U. A., Djajalaksana, S., Listyoko, A. S., & Rasyid, H. A. (2021) · Indonesian Journal of Tropical and Infectious Disease · doi:10.20473/ijtid.v9i3.30874 · Cited by 3
Pediatric transplantation during the COVID-19 pandemic
Kakos, C. D., Ziogas, I. A., & Tsoulfas, G. (2022) · World Journal of Transplantation · doi:10.5500/wjt.v12.i5.88 · Cited by 3
Vince, A. (2020) · Liječnički vjesnik · doi:10.26800/lv-142-3-4-11 · Cited by 3
COVID-19;-The origin, genetics,and management of the infection of mothers and babies
El‐Sayyad, H. I., & Abdalhafid, Y. K. A. (2020) · Egyptian Journal of Basic and Applied Sciences · doi:10.1080/2314808x.2020.1843119 · Cited by 3
The impact of obesity on the cellular and molecular pathophysiology of COVID-19
Dhanraj, P., Pitere, R. R., & Pepper, M. S. (2020) · South African Medical Journal · doi:10.7196/samj.2021.v111i2.15398 · Cited by 3
Mehrpouri, M. (2021) · ACTA MEDICA IRANICA · doi:10.18502/acta.v59i3.5781 · Cited by 3
Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s)
Mohanty, S., Paul, S., & Ahmad, Y. (2021) · VirusDisease · doi:10.1007/s13337-021-00696-1 · Cited by 3
Novel phenotypes of coronavirus disease: a temperature-based trajectory model
Shen, Y., Chen, D., Huang, X., Cai, G., Xu, Q., Hu, C., Yan, J., & Liu, J. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00907-4 · Cited by 3
SARS-COV-2 – the pandemic of the XXI century, clinical manifestations – neurological implications
Saceleanu, V. M., Moreanu, M.-S., Covache-Busuioc, R.-A., Mohan, A. G., & Ciurea, A.-V. (2022) · Journal of Medicine and Life · doi:10.25122/jml-2020-0151 · Cited by 3
Therapeutic Strategies with Synbiotics, Thalidomide, and Celecoxib for Severe COVID-19 PneumoniaPreprint
Hada, M. (2020) · doi:10.22541/au.159188529.93357127 · Cited by 3
Silent cognitive frailty at the interplay between delirium and COVID-19
Boccardi, M., & Boccardi, V. (2021) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2021.102565 · Cited by 3
Najjar, R., Hossain, M. Z., Ahmed, K. A., & Hasan, M. R. (2024) · medRxiv · doi:10.1101/2024.03.17.24304450 · Cited by 3
Aghcheli, B., Behboudi, E., Tabarraei, A., Nikoo, H. R., Rajabi, A., Moradi, A., Nakstad, B., & Tahamtan, A. (2022) · European Journal of Inflammation · doi:10.1177/1721727x221125436 · Cited by 3
Wu, X.-J., Oppelt, K. A., Fan, M., Marie, M. A., Swyers, M. M., Williams, A. J., Lemasson, I., Roper, R. L., Bolin, P., & Yang, L. V. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1549296 · Cited by 2
Qin, Y., Li, C., Yuan, X., & Li, Z. (2025) · Folia Microbiologica · doi:10.1007/s12223-025-01315-y · Cited by 2
COVID-19 is Associated with a Lipid Storm that Worsens in Cases of Severe Pneumonia
Bouabdallah, A., Fradj, M. K. B., Hammami, M. B., Abdelmalek, R., Sanhaji, H., Klopfenstein, T., & Feki, M. (2025) · Microorganisms · doi:10.3390/microorganisms13112622 · Cited by 2
Abolghasemi, H., Kheiri, H., Sedighian, H., Behzadi, E., Kachuei, R., Kheirandish, M., Arabfard, M., & Fooladi, A. A. I. (2025) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2025.100650 · Cited by 2
Huang, J., Reboussin, É., Bianchi, L., Enond, C., Morosan, S., Malet, I., Fouquet, S., Genestant, E., Blond, F., Rostène, W. H., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03722-5 · Cited by 2
Evaluation of mortality predictors in hospitalized COVID-19 patients: Retrospective cohort study
Şener, M. U., Yıldız, M., Kavurgacı, S., Ergür, F. Ö., Şener, A., & Öztürk, A. (2021) · Tuberkuloz ve Toraks · doi:10.5578/tt.20219809 · Cited by 2
Effect of Doxycycline-Release Anastomotic Augmentation Ring on Porcine Colorectal Anastomosis
Luchtefeld, M. A., Jrebi, N. Y., Hostetter, G. H., Osterholzer, K., Dykema, K. J., & Khoo, S. K. (2022) · Journal of Surgical Research · doi:10.1016/j.jss.2022.05.010 · Cited by 2
Raina, R., Singh, S., Enukonda, V., Pandher, D., Abboud, B., Bhola, V., Bagga, S., Zehrer, T., & Desmett, A. L. (2022) · COVID · doi:10.3390/covid2090088 · Cited by 2
Recommended tactics for mass vaccination of healthy individuals and COVID-19 convalescents
Zilfyan, A., Avagyan, S., Muradyan, A. A., & Barsegyan, E. S. (2022) · THE NEW ARMENIAN MEDICAL JOURNAL · doi:10.56936/18290825-2022.16.1-4 · Cited by 2
Lin, Y., Jiang, B., Cai, Y., Luo, W., Zheng, C., Zhu, X., Lin, Q., Tang, M., Li, X., & Xie, L. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1039290 · Cited by 2
Cytokine storm in SARS-CoV-2 infection and the potential treatments
Oktiviyari, A., Hayati, Z., & Zanaria, T. M. (2022) · Trends in Infection and Global Health · doi:10.24815/tigh.v2i1.25901 · Cited by 2
Natural Products Based Antibacterial and Antiviral Materials
Biswal, A., Swain, S., & Swain, S. K. (2023) · ACS symposium series · doi:10.1021/bk-2023-1458.ch008 · Cited by 3
Current Perspective on Vitamins and SARS-CoV-2 Disease (COVID-19)
Goyal, H., Rana, D., Sharma, R., Lamba, D., & Kaur, J. (2023) · Annals of the National Academy of Medical Sciences (India) · doi:10.1055/s-0043-1777316 · Cited by 2
Serum Level of Vitamin K as Predicts Mortality in Iraqi COVID-19 Patients
Al-Mosawei, H. S. M., Ali, H. A., & Al-Tu’ma, F. J. (2024) · Iraq Medical Journal · doi:10.22317/imj.v8i1.1273 · Cited by 2
IP-10, MIP1α, IL-6, and IL-1β as Biomarkers Associated with Disease Severity of COVID-19
Paikar, S., Bahrami, N., Tabatabai, R. R., & Mohamadnia, A. (2024) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-144812 · Cited by 2
Jaishwal, P., Gyaneshwari, U., Jha, K., Pandey, B., Yadav, T. P., & Singh, S. P. (2024) · MedComm – Future Medicine · doi:10.1002/mef2.90 · Cited by 2
Emerging Synthetic Drug Approaches for COVID-19 Treatment: An Extensive Review of Recent Findings
Islam, M. A., Pathak, K., Saikia, R., Pramanik, P., Das, A., Ahmad, M. Z., & Karmakar, S. (2024) · Coronaviruses · doi:10.2174/0126667975278587240817154042 · Cited by 2
Epidemiological and Clinical Characteristics of Fatalities from COVID-19 in Saudi Arabia
Alahmari, A., Alowais, J., & Khan, A. A. (2021) · Journal of Nature and Science of Medicine · doi:10.4103/jnsm.jnsm_107_20 · Cited by 2
A nano perspective behind the COVID-19 pandemic
Silveira, C. P., Schneid, A. D. C., Ribeiro, I. R. S., Galdino, F. E., & Cardoso, M. B. (2021) · Nanoscale Horizons · doi:10.1039/d1nh00135c · Cited by 3
A case report of COVID-19 in a patient with non-Hodgkin’s lymphoma
Eilami, O., Lopes, M. I. B. F., Gryschek, R. C. B., & Taghipour, K. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06472-2 · Cited by 2
Talebian, A., Soltani, B., Aghadoost, D., Azadbakht, J., Rezaee, A., & Abbasy, Z. (2021) · Archives of Pediatric Infectious Diseases · doi:10.5812/pedinfect.115171 · Cited by 2
The Impact of COVID-19 on the Cardiovascular System
Hussein, M. T. E., & Sharma, A. (2022) · Canadian Journal of Emergency Nursing · doi:10.29173/cjen146 · Cited by 2
Lee, Y., Hsu, H., Yang, C., Lin, Y., Chang, S., Yang, R., Liang, J., Chao, T., Liao, C., Kao, H., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071511 · Cited by 2
Sonkar, G. K., Singh, S., & Sonkar, S. K. (2022) · Journal of Diabetology · doi:10.4103/jod.jod_87_22 · Cited by 2
Rubella virus infection in endothelial cells reduces angiogenesis via interferon beta-induced CXCL10
Henschke, V., Hild, K., Schilling, E., Haas, J., Filipova, V., Erbe, S., König, R., Hübschen, J. M., Laufs, U., Claus, C., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106352 · Cited by 2
Neurological manifestations associated with SARS-CoV-2 infection: an updated review.
Macías, D. J. C., Vizcaíno, G., & Siteneski, A. (2023) · Investigación Clínica · doi:10.54817/ic.v64n1a08 · Cited by 2
Macrophage-Induced Exacerbation of Nasopharyngeal Inflammatory Lymphocytes in COVID-19 Disease
Ayass, M., Tripathi, T., Griko, N., Nair, R. R., Zhang, J., Zhu, K., Cao, W., Pashkov, V., Okyay, T., Singh, S., et al. (2023) · COVID · doi:10.3390/covid3040041 · Cited by 2
Raveendra, K. R., Rathod, C., Darnule, R., Loganathan, S., Deodhar, S. S., Radhika, A., Marwah, A., Chaudhari, N. M., Thakur, B. K., Vaidyanathan, S., et al. (2023) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2023.2204186 · Cited by 2
Immune biomarkers associated with COVID-19 disease severity in an urban, hospitalized population
Chambliss, A. B., Aljehani, M. A., Tran, B. H., Chen, X., Elton, E., Garri, C., Ung, N. M., Matasci, N., & Gross, M. E. (2023) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2023.e00323 · Cited by 3
Haselwanter, P., Bal, C., Gompelmann, D., Idzko, M., Prosch, H., Zauner, C., & Schneeweiss‐Gleixner, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175506 · Cited by 2
Targeting chemokine-receptor mediated molecular signaling by ethnopharmacological approaches
Naidu, G., Tripathi, D. K., Nagar, N., Mishra, A., & Poluri, K. M. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117837 · Cited by 2
Özkaya, A. L., Laloğlu, E., Gul, A. H., & Çelik, N. (2024) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2023-0193 · Cited by 2
Atazhakhova, M. G., Chudilova, G. A., Lomtatidze, L. V., & Poezzhaev, E. A. (2024) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-voc-16749 · Cited by 2
Cytokine landscape in hospitalized children with multisystem inflammatory syndrome
Siemińska, I., Bukowska-Straková, K., Surmiak, M., Ptak, K., Szymońska, I., Olchawa-Czech, A., Mól, N., Błyszczuk, P., Sanak, M., Baran, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-73956-x · Cited by 2
Pathogenesis of SARS-CoV-2 and Immune Response in COVID-19
Demırci, M., Ünlü, Ö., Yiğin, A., & Zeyrek, F. Y. (2020) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.5222/tmcd.2020.183 · Cited by 2
Yasin, M., El-Asady, R. S., Elsheikh, N. G., & Mokhtar, M. (2021) · Microbes and Infectious Diseases /Microbes and Infectious Diseases · doi:10.21608/mid.2021.86384.1172 · Cited by 2
[SARS-CoV-2 vaccines induced immune thrombotic thrombocytopenia].
Liu, Y. M., Wang, H. Q., & Shao, Z. (2021) · Europe PMC (PubMed Central) · doi:10.3760/cma.j.issn.0253-2727.2021.07.016 · Cited by 2
Measurement of serum ACE status may potentially improve the diagnosis of SARS-CoV-2 infection
Ngcobo, G. D. (2021) · Scientific African · doi:10.1016/j.sciaf.2021.e01039 · Cited by 2
Dassamiour, S., Ghebache, W., & Gharbi, H. (2022) · Arab Gulf Journal of Scientific Research · doi:10.51758/agjsr-02-2021-0019
Effects of Morphine and Fentanyl on Patients with COVID-19.
Amirsavadkouhi, A., Shahrami, R., Zadeh, N. M., Ilkhani, S., Mirtajani, S. B., Salimi, V., Mahjoubifard, M., & Jahangirifard, A. (2021) · PubMed Central · Cited by 2
Hematological Parameters in COVID-19 Patients: Association with Severity of the Disease.
Abdulla, A. A., Abed, T. A., & Awadh, E. F. A. (2022) · PubMed Central · doi:10.22092/ari.2022.358363.2208 · Cited by 2
A Review on Role of Inflammation in Coronavirus Disease
Lotfi, A., Hajian, P., Abbasi, L., Gargari, M. K., Fard, N. N. G., & Naderi, D. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303265274231204075802 · Cited by 2
Pokhylko, V. I., Cherniavska, Y. I., Fishchuk, L., Rossokha, Z. I., Popova, O., Vershyhora, V., Ievseienkova, O. G., Soloviova, H. O., Zhuk, L. A., & Горовенко, Н. Г. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09569-4 · Cited by 2
Jing, R., Vunnam, R. R., Yang, Y., Karevoll, A., & Vunnam, S. R. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.spl1.10 · Cited by 2
SARS-CoV-2 and COVID-19: A Brief Review for Family Physicians
Mayi, B. S., Raja, A., Foster-Moumoutjis, G., Moran-Walcutt, P., Parmar, M. S., Patricia Rose, R., & Fatteh, S. (2020) · Osteopathic Family Physician · doi:10.33181/12042 · Cited by 2
Evacuation of Electrocautery Smoke: Renewed Consideration During the COVID-19 Pandemic
Ovadia, S. A., & Thaller, S. R. (2020) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000006889 · Cited by 2
Lam, H., & Lacasse, A. (2020) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000925 · Cited by 2
The Pandemic Process: Acquiring Active Immunity Through Art
Oommen, A. (2020) · Art Education · doi:10.1080/00043125.2020.1825599 · Cited by 2
Neutrophils to Lymphocytes Ratio and the Prognosisof the COVID-19 Patients
Taghavi-Farahabadi, M., Mahmoudi, M., Hashemi, S. M., & Namaki, S. (2021) · Immunoregulation · doi:10.32598/immunoregulation.3.2.2 · Cited by 2
Therapeutic and Diagnostic Approaches for SARS-CoV-2
Moshfegh, F., Ezzati, A., Ezzati, A., Bahraini, M., Boluki, E., & Fazeli, A. (2021) · Voice of the Publisher · doi:10.4236/vp.2021.72006 · Cited by 2
Neurological Manifestations of COVID-19
Farhat, S. M. (2021) · Life and Science · doi:10.37185/lns.1.1.162 · Cited by 2
Neuropathogenesis of SARS-CoV-2 Infection
Zahoor, I., Cerghet, M., & Giri, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-82691-4.00006-6 · Cited by 2
Role of Colchicine in Management of COVID-19?
Elshiwy, K., Amin, G. E. E.-D., Nazmy, M., Samir, R. M., & Allam, M. F. (2021) · Global Journal of Epidemiology and Infectious Disease · doi:10.31586/gjeid.2022.177 · Cited by 2
Plasmapherisis in Covid-19 patient under ECMO: A Moroccan case report experience
Laaribi, I., Kachmar, S., Bouayed, M. Z., Mimouni, H., Mekkaoui, I., Rhalete, A. E., Elmouhib, A., Bkiyar, H., & Housni, B. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103250 · Cited by 2
Goyal, A., Saigal, S., Joshi, A., Brahmam, D., Niwariya, Y. K., Khurana, A. K., Singh, P., Kama, S. T., Sharma, J., Khadanga, S., et al. (2022) · Recent Advances in Anti-Infective Drug Discovery · doi:10.2174/2772434417666220817121439 · Cited by 2
Selective Nanotherapeutic Targeting of the Neutrophil Subset Mediating Inflammatory InjuryPreprint
Bachmaier, K., Stuart, A., Hong, Z., Tsukasaki, Y., Singh, A., Chakraborty, S., Mukhopadhyay, A., Gao, X., Maienschein‐Cline, M., Kanteti, P. V. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.30.180927 · Cited by 2
Cytokines mediated hyperinflammation in SARS-CoV2: An Overview
Ali, L. (2020) · Life and Science · doi:10.37185/lns.1.1.147 · Cited by 2
COVID-19 and Indian population: a comparative genetic analysisPreprint
Patil, S., Pemmasani, S. K., Chitturi, N., Bhatnagar, I., Acharya, A., & Subash, L. V. (2021) · medRxiv · doi:10.1101/2021.12.15.21267816 · Cited by 2
In silico prediction of COVID-19 cytokine storm in lung cancer types
Suchanti, S., Awasthi, S., Singh, G., Yadav, P. K., Singh, A., & Mishra, R. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101350 · Cited by 1
Nichols, J. H., Williams, E. P., Parvathareddy, J., Cao, X., Kong, Y., Fitzpatrick, E. A., Webby, R. J., & Jonsson, C. B. (2023) · Viruses · doi:10.3390/v15040946 · Cited by 1
Velmurugan, S., Pauline, R., Kulanthaivel, L., & Subbaraj, G. K. (2024) · Human Gene · doi:10.1016/j.humgen.2024.201308 · Cited by 1
Translational Success and Pharmacoeconomic Lessons of Pandemic-Driven Drug Repurposing
Elechi, K. W., Adeoye, A., Olaniyi, A. O., Akanbi, O. O., Olumeko, I., Udensi, C. G., Kolapo, T. J., & Barrah, V. U. (2025) · Cureus · doi:10.7759/cureus.85033 · Cited by 1
de Lucena, T. M. C., Miranda, D. E. D. O., Arcoverde, J. V. D. B., Cavalcanti, M. S. B., Dantas, W. M., Pena, L., de Lorena, V. M. B., Rabello, M. C. D. S., & Silva, J. D. A. (2025) · Tuberculosis · doi:10.1016/j.tube.2025.102672 · Cited by 1
Role of biomarkers in predicting disease severity in acute dengue and SARs-CoV-2-Infected patients
Yamasmith, E., Kinslow, J. D., Berg, M. G., Cloherty, G., Moy, J. N., LANDAY, A. L., Suputtamongkol, Y., & Tantibhedhyangkul, W. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12196-4 · Cited by 1
Proteomic profiling of mouse lungs after radon inhalation and lipopolysaccharide administration
Naoe, S., Tanaka, A., Takenaka, R., MATOBA, F., Miyaji, T., Yamaoka, K., & Kataoka, T. (2026) · Radiation and Environmental Biophysics · doi:10.1007/s00411-025-01189-1 · Cited by 1
BCG Vaccination Modulates Long-Term TNF-α and sCD40L in COVID-19: An Exploratory Longitudinal Study
Fávero, C., Barbosa, G., Pellegrini, V., Melo, D., Shariat, S. F., Pascoal, L., & Reis, L. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s600024 · Cited by 1
Lehmann, M., Allers, K., Heldt, C., Schmidt, F., Rodriguez‐Sillke, Y., Kunkel, D., Schümann, M., Böttcher, C., Elezkurtaj, S., Bojarski, C., et al. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0041-1734133 · Cited by 1
Metadata
- Authors
- Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M.
- Affiliations
- Istituti Clinici Scientifici Maugeri (IT)
- University of Pavia (IT)
- Corresponding author
- Rotondi, Mario
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 53
- Pages
- 25-32
- ISSN
- 1359-6101 (ISSN-L)
- PMC
- PMC7211650
- OpenAlex
- W3021577619
- Cited by
- 1,288
- References
- 106
- Citations by year
- 2026: 20 · 2025: 44 · 2024: 92 · 2023: 158 · 2022: 274 · 2021: 443 · 2020: 257
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cytokine & Growth Factor Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- cytokine storm, COVID-19 pandemic, SARS-CoV-2, chemokines, chemokine receptors, acute respiratory distress syndrome, systemic inflammation, immune cell recruitment, SARS, MERS, betacoronaviruses, disease severity
- MeSH terms
- Betacoronavirus, Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Humans, Pneumonia, Viral, Coronavirus Infections, Chemokines, Receptors, Chemokine, Severe Acute Respiratory Syndrome, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review